Jun 25, 2019
Another pharma megamerger: AbbVie buys Allergan for $63 billion
Both companies are under pressure to improve their performance.
PHILIPPE HUGUEN/AFP/Getty Images
Earlier this year, Bristol-Myers Squibb announced it was buying Celgene for $74 billion. Now AbbVie, which makes popular drug Humira, has entered into an agreement to pay about $63 billion for Allergan, the manufacturer of Botox. What’s in it for both companies?
Click the audio player above to hear the full story.
Latest Episodes
View All Shows
10 hours ago25:19
16 hours ago19:00
18 hours ago6:55
a day ago8:33
3 days ago56:05
24 days ago32:45